Mark Walchirk
While CEO Mark Walchirk’s management approach and discipline receive praise, doubts persist about his skill in steering through dental distribution sector challenges.
Industry insiders acknowledge Walchirk’s leadership respect but question his ability to offset structural shifts weakening Patterson’s market stance.
Walchirk’s McKesson tenure during the opioid crisis invites scrutiny, yet no misconduct is indicated; his leadership will face close observation amid active litigation.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.